| Date Initiated by Firm | October 08, 2009 |
| Date Posted | November 17, 2009 |
| Recall Status1 |
Terminated 3 on April 02, 2012 |
| Recall Number | Z-0273-2010 |
| Recall Event ID |
53615 |
| 510(K)Number | K934370 |
| Product Classification |
kit, needle, biopsy - Product Code FCG
|
| Product | Bard Magnum Disposable Biopsy Core Needle 16 gauge, Catalog Number: MN1610.
Bard Magnum Disposable Biopsy Core Needle is intended for use in obtaining biopsies from soft tissues such as liver, kidney, prostate, breast, spleen, lymph nodes and various soft tissue tumors |
| Code Information |
Lot Number: REQI0640 REQJ0110 REQK0190 REQK0376 REQK0818 REQL0207 RERA0671 RERB0028 RERB0580 RERC0286 RERD0535 RERE0157 RERE0679 RERE0825 RERG0081 RERH0338 RERH0484 RERH1054 RERI0145 RERI0583 RERJ0007 RERJ0564 RERK0165 RERK0261 RERK0706 RERL0186 RESA0227 RESA0230 RESA0822 RESB0375 RESB0978 RESC0424 RESD0095 RESD0591 RESE0372 RESF0027 RESF0558 RESF0725 RESG0412 RESH0055 RESH0717 RESI0709 RESK0646 Lot Number REQI0640 REQJ0110 REQK0190 REQK0376 REQK0818 REQL0207 RERA0671 RERB0028 RERB0580 RERC0286 RERD0535 RERE0157 RERE0679 RERE0825 RERG0081 RERH0338 RERH0484 RERH1054 RERI0145 RERI0583 RERJ0007 RERJ0564 RERK0165 RERK0261 RERK0706 RERL0186 RESA0227 RESA0230 RESA0822 RESB0375 RESB0978 RESC0424 RESD0095 RESD0591 RESE0372 RESF0027 RESF0558 RESF0725 RESG0412 RESH0055 RESH0717 RESI0709 RESK0646 and RETC0214 |
Recalling Firm/ Manufacturer |
Bard Peripheral Vascular Inc 1625 W 3rd St Tempe AZ 85281-2438
|
| For Additional Information Contact | 480-894-9515 |
Manufacturer Reason for Recall | The recall was initiated after the firm determined that some Magnum Disposable Biopsy Core Needle 16 gauge lots may exhibit an exposed sample chamber, due to extended stylet length resulting from a loose hub connection. The exposed sample chamber will typically result in an inability to obtain the biopsy sample. In the majority of reported cases, there was no injury to the patient or user. When us |
FDA Determined Cause 2 | Process design |
| Action | The recall notification was initiated by the firm issuing an urgent medical device notification to it's consignees on October 08, 2009 via USPS requesting them to check all inventory locations for the affected products, remove and return affected products to Bard. The consignees were instructed to complete and return a recall effectiveness check form. Bard provided this 800 number 1-800-321-4254 for any questions consignees may have. |
| Quantity in Commerce | 127,169 units |
| Distribution | Nationwide and internationally to
Canada
Mexico
Algeria
Andorra
Austria
Bahrain
Belarus
Belgium
Croatia
Cyprus
Czech Republic
Denmark
Finland
France
French Guiana
Germany
Gibraltar
Greece
Hungary
Ireland
Israel
Italy
Ivory Coast
Kenya
Kuwait
Latvia
Lebanon
Luxembourg
Malta
Martinique
Mauritius
Morocco
Netherlands
New Caledonia
Nigeria
Norway
Oman
Poland
Portugal
Republic of Kosovo
Republic of Macedonia
Reunion
Romania
Russia
Saudi Arabia
Senegal
Serbia
Seychelles
Slovenia
South Africa
Spain
Sweden
Switzerland
Syria
Tunisia
Turkey
Ukraine
United Arab Emirates
United Kingdom
Australia
New Zealand
Canada
Japan
Bangladesh
China
Hong Kong
India
Indonesia
Korea
Malaysia
Pakistan
Singapore
Sri Lanka
Taiwan
Thailand
Vietnam
Argentina
Bahamas
Barbados
Brazil
Chile
Colombia
Dominican Republic
Mexico
Peru and
Suriname |
| Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
| 510(K) Database | 510(K)s with Product Code = FCG
|